The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

A&g Pharmaceutical Inc dba Precision Antibody

  • Contact Person: Michael Keefe
  • Contact Phone: 410-884-4100
  • Contact Email: mkeefe@agpharma.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • For Profit Organization
  • Manufacturer of Goods
  • Industries Served: Pharmaceutical Preparation Manufacturing, In-Vitro Diagnostic Substance Manufacturing, Other Scientific and Technical Consulting Services, Medical Laboratories
  • Product Areas: R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), LIFE SCIENCES (APPLIED/EXPLORATORY), BIOMEDICAL (ADVANCED), R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT), R&D- MEDICAL: BIOMEDICAL (MANAGEMENT/SUPPORT), BIOMEDICAL (MANAGEMENT/SUPPORT), R&D- MEDICAL: DRUG DEPENDENCY (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), R&D-DRUG DEPENDENCY-A RES/EXPL DEV, STUDY/CHEMICAL-BIOLOGICAL, SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $67,200 - Monday the 26th of November 2012
    Food And Drug Administration
    DEPT OF HHS/FOOD AND DRUG ADMINISTRATION
    OTHER FUNCTIONS - EXERCISE OPTION 1 FOR MONOCLONAL ANTIBODY PRODUCTION
  • $199,380 - Tuesday the 25th of June 2013
    National Institutes Of Health
    NIH, NCI, OD OM OA OFC ACQUISITIONS
    IGF::OT::IGF R&D MEDICAL: BIOMEDICAL

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.